17/10/2025
Available Worldwide
Ponaxen 45 mg (Ponatinib) – Advanced Leukemia Therapy
🔬 Manufactured by: Everest Pharmaceuticals
🛒 Order now: naharmeds.com
A powerful targeted therapy for resistant blood cancers
✔️ Third-generation BCR-ABL inhibitor
✔️ Effective for T315I mutation patients
✔️ Trusted treatment for CML & Ph+ ALL
📄 Prescription is strictly required before purchase
“Limited global stock – secure your course today!”
💊 What is Ponaxen (Ponatinib) Used For?
Ponaxen 45 mg (Ponatinib) is used in the treatment of:
🔹 Chronic Myeloid Leukemia (CML)
🔹 Philadelphia chromosome–positive Acute Lymphoblastic Leukemia (Ph+ ALL)
It is especially beneficial for patients resistant or intolerant to prior therapies, or with the T315I mutation. Ponaxen works by blocking abnormal proteins that drive cancer cell growth, helping control disease progression.